Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $16.65 USD
Change Today +0.34 / 2.08%
Volume 475.0K
THRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mathai Mammen M.D., Ph.D.

Co-Founder, Theravance Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

47--
As of Fiscal Year 2014

Background*

Dr. Mathai Mammen, M.D., Ph.D. has been Senior Vice President of Research & Development at Theravance Biopharma, Inc. since October 2014. Dr. Mammen Co-founded Theravance Inc. in 1996, and served as its Senior Vice President of Research & Early Clinical Development since February 2009 until September 30, 2014. Dr. Mammen served as Senior Vice President of Research of Theravance Inc. since April 2008. Dr. Mammen served as Vice President of Theravance's Molecular and Cellular ...

Read Full Background

Corporate Headquarters*

951 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-238-9600
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Dalhousie University
MD
Harvard Medical School
PhD
Department of Chemistry&Chemical Biology, Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THRX:US $16.65 USD +0.34

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
$500.0K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAVANCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.